The 40th Annual Summer Meeting of The Toxicology Forum

July 7-10, 2014 · St. Regis Aspen, Aspen, Colorado

The Dialogue Continues…


The Toxicology Forum announces its upcoming summer meeting at the St Regis Hotel in Aspen, Colorado.


The Toxicology Forum meeting provides a unique opportunity for industry, academic, and government scientists to discuss the scientific underpinnings of health policies, guidance, and regulations. This year’s meeting discussion will address new insights on continuing issues and initiate the dialog on emerging approaches to foster regulatory decisions.


Registration Form


Keynote Speaker:

Kenneth Olden, USEPA/NCEA
The IRIS Program: Enhancements, Opportunities and Scientific Challenges



The Toxicology Forum is undergoing administrative and programmatic changes designed to ensure sustainability and growth into the future. This session will provide an opportunity for all participants to engage in the discussion to ensure the changes meet the needs of the entire toxicology community. The session will take place on Tuesday afternoon.


Sessions Include:

Caffeine: Critical Science Issues and Public Health Consequences

The successful marketing of “energy drinks” to young adults has raised to new concerns about the safety of caffeine consumption. This session will address the reproductive, cardiovascular and neurological effects of caffeine in light of the new uses. This session will review the health consequences and discuss the new scientific evidence.


Biological Correlations and Associations:  How Do We Improve Analysis and Interpretation for Regulatory Decision Making?

This session will focus on the interpretation of biomarker data and when and how it can be used to make informed decisions on risk. Good and bad examples will be addressed along with additional considerations for drawing correct conclusions.


New Approaches to Identify Adaptive/Adverse Responses

This session continues the theme of adaptive and adverse responses with a focus on the toxicology on adverse outcome pathways, key events in mode of action of the toxicity pathways, and how new techniques can help with rational risk assessment decisions. Case studies will be used to illustrate data needs.


Mouse Lung Tumors

This session will explore the human relevance of mouse lung tumors and how one can characterize tumors to allow for science-based decision-making.


Designing a Surveillance Strategy for Food Ingredients

At the time of approval the usage of food ingredients is estimated and if true use differs from that estimate it remains unknown until there is a problem. The USFDA and industry have been discussing how to collect and interpret food ingredient use information.


Impact of Food Wars on Agricultural Biotechnology: What is the Truth and How Can It Be Told?

This session will cover the science and politics of GMO products used in agriculture, discuss what has been learned from this experience, and how to avoid controversies that stifle innovation.


The Science and Potential of RNAi.

This session was designed to introduce the forum to the new technology of RNAi, and discuss possible uses in agriculture and pharmaceuticals. We will explore some of the misinformation about this technology and how the regulators should address these concerns. The use applicability and factors that need to be considered for the safe implementation of the technology will be addressed.


Establishing Thresholds for Allergens

This session will revisit the scientific progress being made in establishing a threshold for allergens.


Hot Topics

There are plenty of Hot Topics to address each year.  You must be there to ensure you do not miss out on those that emerge in Aspen this July.